Cite
MLA Citation
Andrew J. Flores et al.. “The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia.” Neuropharmacology, vol. 141, 2018, pp. 260–271. http://access.bl.uk/ark:/81055/vdc_100069104533.0x00005b